Your browser doesn't support javascript.
loading
T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.
Wang, Jiachen; Shen, Kefeng; Mu, Wei; Li, Weigang; Zhang, Meilan; Zhang, Wei; Li, Zhe; Ge, Tong; Zhu, Zhoujie; Zhang, Shangkun; Chen, Caixia; Xing, Shugang; Zhu, Li; Chen, Liting; Wang, Na; Huang, Liang; Li, Dengju; Xiao, Min; Zhou, Jianfeng.
Afiliação
  • Wang J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shen K; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Mu W; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li W; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Zhang M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang W; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Li Z; Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ge T; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhu Z; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Zhang S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chen C; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Xing S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhu L; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Chen L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang N; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
  • Huang L; Perfectgen Diagnostics, Ezhou, China.
  • Li D; Wuhan Bio-Raid Biotechnology Co., Ltd., Wuhan, China.
  • Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhou J; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.
Front Immunol ; 13: 873789, 2022.
Article em En | MEDLINE | ID: mdl-35572515
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article